CRT Capital to host a conference 1:1 Investor Conference is being held in Greenwich, CT on September 23. Forest Labs announces FDA designates ceftazidime/avibactam as QIDP Forest Laboratories announced that the U.S. FDA has designated its investigational drug, ceftazidime/avibactam, a qualified infectious disease product.
http://www.theflyonthewall.com/permalinks/entry.php/FRXid1891441/FRX-Forest-Labs-files-patent-infringement-suits-against-several-companies-
http://www.theflyonthewall.com/permalinks/entry.php/FRXid1891441/FRX-Forest-Labs-files-patent-infringement-suits-against-several-companies-
No comments:
Post a Comment
Useful criticism, helpful links and corrections and general comments are always welcome at Greenwich Roundup. Generally only spam ads and posts with very foul language get censored.
Contact me directly at GreenwichRoundup@gmail.com if you have a suggestion or comment you don't want publicized (but tell me so in your email).
I look forward to publishing your opinions.
COMMENTING RULES: We encourage an open exchange of ideas in the Greenwich community, but we ask you to follow our guidelines. Basically, be civil, smart, on-topic and free from profanity. Don't say anything you wouldn't want your mother to read!